AxoGen Inc
NASDAQ:AXGN

Watchlist Manager
AxoGen Inc Logo
AxoGen Inc
NASDAQ:AXGN
Watchlist
Price: 11.07 USD 1.19% Market Closed
Market Cap: 490.8m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+95%
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

AXGN Price Targets Summary
AxoGen Inc

Wall Street analysts forecast AXGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AXGN is 26.65 USD with a low forecast of 24.24 USD and a high forecast of 31.5 USD.

AXGN Lowest Forecast
Wall Street Target
24.24 USD
119% Upside
AXGN Average Forecast
Wall Street Target
26.65 USD
141% Upside
AXGN Highest Forecast
Wall Street Target
31.5 USD
185% Upside
Lowest
Price Target
24.24 USD
119% Upside
Average
Price Target
26.65 USD
141% Upside
Highest
Price Target
31.5 USD
185% Upside
AxoGen Inc Competitors:
Price Targets
NVCR
Novocure Ltd
83% Upside
L
2291
Lepu Scientech Medical Technology Shanghai Co Ltd
0% Downside
688580
Nanjing Vishee Medical Technology Co Ltd
3% Upside
ATRC
AtriCure Inc
57% Upside
NVCR
Novocure Ltd
83% Upside
L
2291
Lepu Scientech Medical Technology Shanghai Co Ltd
0% Downside
688580
Nanjing Vishee Medical Technology Co Ltd
3% Upside
ATRC
AtriCure Inc
57% Upside
I
041830
InBody Co Ltd
43% Upside
N
NXTMH
Nexstim Oyj
17% Upside
L
300003
Lepu Medical Technology Beijing Co Ltd
22% Upside
B
2216
Broncus Holding Corp
28% Downside

Revenue
Forecast

Revenue Estimate
AxoGen Inc

For the last 8 years the compound annual growth rate for AxoGen Inc's revenue is 21%. The projected CAGR for the next 3 years is 17%.

21%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
AxoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
32%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
AxoGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
53%
Average Beat
What are analyst estimates?

See Also

Summary
AXGN intrinsic value, competitors valuation, and company profile.
DCF Valuation
AXGN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AXGN stock valuation using valuation multiples.
Wall Street Estimates
AXGN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AXGN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AXGN's stock price target?
Price Target
26.65 USD

According to Wall Street analysts, the average 1-year price target for AXGN is 26.65 USD with a low forecast of 24.24 USD and a high forecast of 31.5 USD.

What is AxoGen Inc's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for AxoGen Inc's revenue is 21%. The projected CAGR for the next 3 years is 17%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.